Fusion event
HBV-chr5 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAG| |GTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGT
End
18228464/18228355 (Hg38)
Nearest miRNA
hsa-mir-10397/Upstream/1072363; hsa-mir-103a-1/Downstream/13707747;
Upstream sequence
CTTTTAAATTATTCCTTTTTATCTTCAATTGTTTATACAGGTTTAACGGCAACAATCTTAACTAACAACAAGTAATGCCCTGGCTATTTATTGTACCATC
Downstream sequence
gtgcgttcctatttattacctgagaagaggtttcttatagcacacttatggacagtaaaaggaaaagcaaagcaaacttactcactgtttgctggcaaaa
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.